Part 2 - PHARMACY PRACTICE
- Section 63-10-201 - Short title
- Section 63-10-202 - Practice of pharmacy
- Section 63-10-203 - Statement of purpose
- Section 63-10-204 - Definitions
- Section 63-10-205 - Consultation on drugs by board to department of health
- Section 63-10-206 - Sale of nonprescription drugs and devices
- Section 63-10-207 - Dispensing of medication prior to authorization
- Section 63-10-208 - Penalty for violation
- Section 63-10-209 - Distribution of drugs or drug samples by manufacturer's representative - Distribution of free samples
- Section 63-10-210 - Registration fees for out-of-state pharmacies mailing into Tennessee
- Section 63-10-211 - Consortia for bulk purchases authorized
- Section 63-10-212 - Confidentiality of information entrusted to pharmacist
- Section 63-10-213 - Legibility of prescriptions
- Section 63-10-214 - Centralized prescription processing - Licensing - Rules
- Section 63-10-215 - Transfer of prescriptions to another prescription form
- Section 63-10-216 - Compounding pharmacies
- Section 63-10-217 - Collaborative pharmacy practice agreements
- Section 63-10-218 - Professional judgment in dispensing of varying quantities of medication not to exceed ninety-day supply - Exclusion of controlled substances
- Section 63-10-219 - Provision of hormonal contraceptives
- Section 63-10-220 - Facilities engaging in distribution of dialysate and devices for home use
- Section 63-10-221 - Medication therapy management - Standards
- Section 63-10-222 - Medication therapy management pilot program - Reporting of costs and patient outcomes
- Section 63-10-223 - Agreement limiting ability of pharmacist to discuss issue related to dispensing of controlled substance with patient void and unenforceable
- Section 63-10-224 - Provision of ivermectin by pharmacists
- Section 63-10-225 - Notification of lowest available cost for prescription drugs—Explanation of effect on insurance—Immunity from civil liability